Ms. Alyssa Jan Cohen, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 57 Winterberry Cir, Cross River, NY 10518 Phone: 914-924-2704 |
Mrs. Dale Susan Lichtenstein Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5 Adams Hill Rd, Cross River, NY 10518 Phone: 914-441-1723 |
Laureen Leffkowitz Curry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 892 Route 35, Cross River, NY 10518 Phone: 914-763-3278 |
News Archive
The antiviral drug amantadine can prevent some cases of influenza in children, and the related medication rimantadine can reduce fever in youngsters who have the flu, according to a new review of evidence.
As of this year, kids under the age of 15 only need 2 doses of HPV vaccine. New research out of Boston Medical Center, published online in the STD Journal, is the first published clinical evidence to support new recommendations by the Center for Disease Control and Prevention for a two-dose HPV vaccine to prevent genital warts.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
Merix Pharmaceutical Corp. unveiled its new Fast-Results!™ Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that it closed on $5.9 million in additional private financing during the second half of 2009, bringing the total the company raised in 2009 to $7.1 million.
› Verified 6 days ago